The International Council for Harmonisation (ICH): 'E' group of guidelines
Below is the overview of 'E' group of ICH guidelines that collectively apply to different stages and types of pre- / clinical research and development.
|
ICH: ‘E’ group of guidelines overview
| |
| General Considerations for Clinical Studies: | |
|
Design and Analysis: | E4 Dose-Response Studies |
| E9 Statistical principles for Clinical Trials | |
| E10 Choice of Control Group in Clinical Trials | |
| E17 Multi-Regional Clinical Trials | |
| Conduct and Reporting: | E3 Clinical Study Reports |
| |
| Safety Reporting: | E1 Clinical Safety for Drugs used in Long-Term Treatment |
| E2A – E2F Pharmacovigilance | |
| E14 Clinical Evaluation of QT | |
| E19 Safety Data Collection | |
|
Populations: | E5 Ethnic Factors |
| E7 Clinical Trials in Geriatric Population | |
| E11 – E11A Clinical Trials in Pediatric Polulations | |
| E12 Clinical Evaluation by Therapeutic Category | |
| Genetics / Genomics | E15 Definitions in Pharmacogenetics/Pharmacogenomics |
| E16 Qualification of Genomic Biomarkers | |
| E18 Genomic Sampling | |
Other EU Guidelines:
Author: European Medicines Agency
Clinical Research News
即将进行的临床试验
-
National Institute of Dental and Craniofacial Research...National Institute of Neurological Disorders and Stroke (NINDS); Sorrento Therapeutics, Inc.招聘中
-
National Cancer Institute (NCI)Children's Oncology Group招聘中恶性实体肿瘤 | 晚期恶性实体瘤 | 难治性恶性实体瘤 | 复发性室管膜瘤 | 复发性肝母细胞瘤 | 复发性朗格汉斯细胞组织细胞增生症 | 复发性恶性生殖细胞肿瘤 | 复发性恶性胶质瘤 | 复发性恶性实体瘤 | 复发性髓母细胞瘤 | 复发性神经母细胞瘤 | 复发性非霍奇金淋巴瘤 | 复发性骨肉瘤 | 复发性横纹肌样瘤 | 复发性横纹肌肉瘤 | 复发性软组织肉瘤 | 难治性室管膜瘤 | 难治性肝母细胞瘤 | 难治性朗格汉斯细胞组织细胞增生症 | 难治性恶性生殖细胞瘤 | 难治性恶性胶质瘤 | 难治性髓母细胞瘤 | 难治性神经母细胞瘤 | 难治性非霍奇金淋巴瘤 | 难治性骨肉瘤 | 难治性横纹肌样瘤 | 难治性横纹肌肉瘤 | 难治性软组织肉瘤 | 肾母细胞瘤 | 复发性原发性中枢神经系统肿瘤 | 难治性原发性中枢神经系统肿瘤 | 复发性尤文肉瘤/外周原始神经外胚层肿瘤 及其他条件美国, 波多黎各, 澳大利亚, 加拿大
-
Universidad Pontificia ComillasHospital General Universitario Gregorio Marañon; San Juan de Dios Foundation招聘中
-
Universidad Nacional Andres Bello尚未招聘
